Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 203 entries
Sorted by: Best Match Show Resources per page
Participants in urban Mexican male homosexual encounters.

Archives of sexual behavior

Carrier JM.
PMID: 24179076
Arch Sex Behav. 1971 Dec;1(4):279-91. doi: 10.1007/BF01638057.

Preliminary data are presented on 53 urban Mexican males interviewed during 1970-1971 in a study of homosexual encounters in a large Mexican city. These data are compared with data from recent studies in the United States and England of...

Cite
Carrier JM. Participants in urban Mexican male homosexual encounters. Arch Sex Behav. 1971;1(4):279-91doi: 10.1007/BF01638057.
Carrier, J. M. (1971). Participants in urban Mexican male homosexual encounters. Archives of sexual behavior, 1(4), 279-91. https://doi.org/10.1007/BF01638057
Carrier, J M. "Participants in urban Mexican male homosexual encounters." Archives of sexual behavior vol. 1,4 (1971): 279-91. doi: https://doi.org/10.1007/BF01638057
Carrier JM. Participants in urban Mexican male homosexual encounters. Arch Sex Behav. 1971 Dec;1(4):279-91. doi: 10.1007/BF01638057. PMID: 24179076.
Copy Download .nbib Format: NLM
Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy.

Open forum infectious diseases

Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS.
PMID: 30793009
Open Forum Infect Dis. 2019 Feb 12;6(2):ofz022. doi: 10.1093/ofid/ofz022. eCollection 2019 Feb.

BACKGROUND: Racial/ethnic disparities in HIV outcomes have persisted despite effective antiretroviral therapy. In a study of initial regimens, we found viral suppression varied by race/ethnicity. In this exploratory analysis, we use clinical and socioeconomic data to assess factors associated...

Cite
Bhagwat P, Kapadia SN, Ribaudo HJ, et al. Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open Forum Infect Dis. 2019;6(2):ofz022doi: 10.1093/ofid/ofz022.
Bhagwat, P., Kapadia, S. N., Ribaudo, H. J., Gulick, R. M., & Currier, J. S. (2019). Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open forum infectious diseases, 6(2), ofz022. https://doi.org/10.1093/ofid/ofz022
Bhagwat, Priya, et al. "Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy." Open forum infectious diseases vol. 6,2 (2019): ofz022. doi: https://doi.org/10.1093/ofid/ofz022
Bhagwat P, Kapadia SN, Ribaudo HJ, Gulick RM, Currier JS. Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy. Open Forum Infect Dis. 2019 Feb 12;6(2):ofz022. doi: 10.1093/ofid/ofz022. eCollection 2019 Feb. PMID: 30793009; PMCID: PMC6372057.
Copy Download .nbib Format: NLM
Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging.

Cureus

Delouya G, Carrier JF, Xavier-Larouche R, Hervieux Y, Béliveau-Nadeau D, Donath D, Taussky D.
PMID: 29850389
Cureus. 2018 Mar 29;10(3):e2394. doi: 10.7759/cureus.2394.

Purpose To compare the impact of the fusion of intraoperative transrectal ultrasound (TRUS) images with day 30 computed tomography (CT) and magnetic resonance imaging (MRI) on prostate volume and dosimetry. Methods and materials Seventy-five consecutive patients with CT and...

Cite
Delouya G, Carrier JF, Xavier-Larouche R, et al. Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus. 2018;10(3):e2394doi: 10.7759/cureus.2394.
Delouya, G., Carrier, J. F., Xavier-Larouche, R., Hervieux, Y., Béliveau-Nadeau, D., Donath, D., & Taussky, D. (2018). Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus, 10(3), e2394. https://doi.org/10.7759/cureus.2394
Delouya, Guila, et al. "Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging." Cureus vol. 10,3 (2018): e2394. doi: https://doi.org/10.7759/cureus.2394
Delouya G, Carrier JF, Xavier-Larouche R, Hervieux Y, Béliveau-Nadeau D, Donath D, Taussky D. Fusion of Intraoperative Transrectal Ultrasound Images with Post-implant Computed Tomography and Magnetic Resonance Imaging. Cureus. 2018 Mar 29;10(3):e2394. doi: 10.7759/cureus.2394. PMID: 29850389; PMCID: PMC5973483.
Copy Download .nbib Format: NLM
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2).

Frontiers in cell and developmental biology

D'Cruz RJ, Currier AW, Sampson VB.
PMID: 32582718
Front Cell Dev Biol. 2020 Jun 04;8:468. doi: 10.3389/fcell.2020.00468. eCollection 2020.

Following the first reports of coronavirus disease-19 (COVID-19) by China to the World Health Organization (WHO) on 31st December 2019, more than 4,302,774 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cases have been reported by authorities in 212 countries...

Cite
D'Cruz RJ, Currier AW, Sampson VB. Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Front Cell Dev Biol. 2020;8:468doi: 10.3389/fcell.2020.00468.
D'Cruz, R. J., Currier, A. W., & Sampson, V. B. (2020). Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Frontiers in cell and developmental biology, 8468. https://doi.org/10.3389/fcell.2020.00468
D'Cruz, Roshan J, et al. "Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)." Frontiers in cell and developmental biology vol. 8 (2020): 468. doi: https://doi.org/10.3389/fcell.2020.00468
D'Cruz RJ, Currier AW, Sampson VB. Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Front Cell Dev Biol. 2020 Jun 04;8:468. doi: 10.3389/fcell.2020.00468. eCollection 2020. PMID: 32582718; PMCID: PMC7287038.
Copy Download .nbib Format: NLM
Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences.

Journal of AIDS & clinical research

Cheng QJ, Engelage EM, Grogan TR, Currier JS, Hoffman RM.
PMID: 25914854
J AIDS Clin Res. 2014 Nov;5(11). doi: 10.4172/2155-6113.1000366.

BACKGROUND: Non-AIDS co-morbidities are emerging as the main health problems for those living with HIV, and primary care for this population is an evolving challenge. Recent studies have raised the question of whether specialists or generalists are best suited...

Cite
Cheng QJ, Engelage EM, Grogan TR, et al. Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res. 2014;5(11)doi: 10.4172/2155-6113.1000366.
Cheng, Q. J., Engelage, E. M., Grogan, T. R., Currier, J. S., & Hoffman, R. M. (2014). Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. Journal of AIDS & clinical research, 5(11), . https://doi.org/10.4172/2155-6113.1000366
Cheng, Quen J, et al. "Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences." Journal of AIDS & clinical research vol. 5,11 (2014). doi: https://doi.org/10.4172/2155-6113.1000366
Cheng QJ, Engelage EM, Grogan TR, Currier JS, Hoffman RM. Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res. 2014 Nov;5(11). doi: 10.4172/2155-6113.1000366. PMID: 25914854; PMCID: PMC4409003.
Copy Download .nbib Format: NLM
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus.

Open forum infectious diseases

Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, Overton ET, Okeke NL, Kumar P, Joao E, Aberg JA, Martinez E, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK.
PMID: 34888395
Open Forum Infect Dis. 2021 Nov 20;8(12):ofab537. doi: 10.1093/ofid/ofab537. eCollection 2021 Dec.

BACKGROUND: Emerging data demonstrate that the use of integrase inhibitor (INSTI)-based antiretroviral treatment (ART) is associated with increased weight, but the cardiometabolic health consequences of increased weight remains poorly understood.METHODS: This analysis examined INSTI use (>6 months) at entry...

Cite
Kileel EM, Lo J, Malvestutto C, et al. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021;8(12):ofab537doi: 10.1093/ofid/ofab537.
Kileel, E. M., Lo, J., Malvestutto, C., Fitch, K. V., Zanni, M. V., Fichtenbaum, C. J., Overton, E. T., Okeke, N. L., Kumar, P., Joao, E., Aberg, J. A., Martinez, E., Currier, J. S., Douglas, P. S., Ribaudo, H. J., & Grinspoon, S. K. (2021). Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open forum infectious diseases, 8(12), ofab537. https://doi.org/10.1093/ofid/ofab537
Kileel, Emma M, et al. "Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus." Open forum infectious diseases vol. 8,12 (2021): ofab537. doi: https://doi.org/10.1093/ofid/ofab537
Kileel EM, Lo J, Malvestutto C, Fitch KV, Zanni MV, Fichtenbaum CJ, Overton ET, Okeke NL, Kumar P, Joao E, Aberg JA, Martinez E, Currier JS, Douglas PS, Ribaudo HJ, Grinspoon SK. Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus. Open Forum Infect Dis. 2021 Nov 20;8(12):ofab537. doi: 10.1093/ofid/ofab537. eCollection 2021 Dec. PMID: 34888395; PMCID: PMC8651160.
Copy Download .nbib Format: NLM
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.

bioRxiv : the preprint server for biology

Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie L, Venkatachalam T, Arnold S, Alvarado LHA, Catalfano K, Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J, Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A, Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary C, Laporte S, Lenkeit E, Martin K, Orellana M, de la Campa MO, Paredes I, Wheeler B, Rupert A, Sam A, See K, Zapata SS, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA, Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD, Burley SK.
PMID: 33299989
bioRxiv. 2020 Dec 07; doi: 10.1101/2020.12.01.406637.

Three-dimensional structures of SARS-CoV-2 and other coronaviral proteins archived in the Protein Data Bank were used to analyze viral proteome evolution during the first six months of the COVID-19 pandemic. Analyses of spatial locations, chemical properties, and structural and...

Cite
Lubin JH, Zardecki C, Dolan EM, et al. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic. bioRxiv. 2020;doi: 10.1101/2020.12.01.406637.
Lubin, J. H., Zardecki, C., Dolan, E. M., Lu, C., Shen, Z., Dutta, S., Westbrook, J. D., Hudson, B. P., Goodsell, D. S., Williams, J. K., Voigt, M., Sarma, V., Xie, L., Venkatachalam, T., Arnold, S., Alvarado, L. H. A., Catalfano, K., Khan, A., McCarthy, E., Staggers, S., Tinsley, B., Trudeau, A., Singh, J., Whitmore, L., Zheng, H., Benedek, M., Currier, J., Dresel, M., Duvvuru, A., Dyszel, B., Fingar, E., Hennen, E. M., Kirsch, M., Khan, A. A., Labrie-Cleary, C., Laporte, S., Lenkeit, E., Martin, K., Orellana, M., de la Campa, M. O., Paredes, I., Wheeler, B., Rupert, A., Sam, A., See, K., Zapata, S. S., Craig, P. A., Hall, B. L., Jiang, J., Koeppe, J. R., Mills, S. A., Pikaart, M. J., Roberts, R., Bromberg, Y., Hoyer, J. S., Duffy, S., Tischfield, J., Ruiz, F. X., Arnold, E., Baum, J., Sandberg, J., Brannigan, G., Khare, S. D., & Burley, S. K. (2020). Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.12.01.406637
Lubin, Joseph H, et al. "Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.12.01.406637
Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z, Dutta S, Westbrook JD, Hudson BP, Goodsell DS, Williams JK, Voigt M, Sarma V, Xie L, Venkatachalam T, Arnold S, Alvarado LHA, Catalfano K, Khan A, McCarthy E, Staggers S, Tinsley B, Trudeau A, Singh J, Whitmore L, Zheng H, Benedek M, Currier J, Dresel M, Duvvuru A, Dyszel B, Fingar E, Hennen EM, Kirsch M, Khan AA, Labrie-Cleary C, Laporte S, Lenkeit E, Martin K, Orellana M, de la Campa MO, Paredes I, Wheeler B, Rupert A, Sam A, See K, Zapata SS, Craig PA, Hall BL, Jiang J, Koeppe JR, Mills SA, Pikaart MJ, Roberts R, Bromberg Y, Hoyer JS, Duffy S, Tischfield J, Ruiz FX, Arnold E, Baum J, Sandberg J, Brannigan G, Khare SD, Burley SK. Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic. bioRxiv. 2020 Dec 07; doi: 10.1101/2020.12.01.406637. PMID: 33299989; PMCID: PMC7724657.
Copy Download .nbib Format: NLM
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.

JAMA network open

Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J, Taron J, Zhai BK, Burdo T, Fitch KV, Kileel EM, Williams K, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg J, Currier J, Sponseller CA, Melbourne K, Floris-Moore M, Van Dam C, Keefer MC, Koletar SL, Douglas PS, Ribaudo H, Mayrhofer T, Grinspoon SK.
PMID: 34185068
JAMA Netw Open. 2021 Jun 01;4(6):e2114923. doi: 10.1001/jamanetworkopen.2021.14923.

IMPORTANCE: Cardiovascular disease (CVD) is increased among people with HIV (PWH), but little is known regarding the prevalence and extent of coronary artery disease (CAD) and associated biological factors in PWH with low to moderate traditional CVD risk.OBJECTIVES: To...

Cite
Hoffmann U, Lu MT, Foldyna B, et al. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021;4(6):e2114923doi: 10.1001/jamanetworkopen.2021.14923.
Hoffmann, U., Lu, M. T., Foldyna, B., Zanni, M. V., Karady, J., Taron, J., Zhai, B. K., Burdo, T., Fitch, K. V., Kileel, E. M., Williams, K., Fichtenbaum, C. J., Overton, E. T., Malvestutto, C., Aberg, J., Currier, J., Sponseller, C. A., Melbourne, K., Floris-Moore, M., Van Dam, C., Keefer, M. C., Koletar, S. L., Douglas, P. S., Ribaudo, H., Mayrhofer, T., Grinspoon, S. K. (2021). Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA network open, 4(6), e2114923. https://doi.org/10.1001/jamanetworkopen.2021.14923
Hoffmann, Udo, et al. "Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention." JAMA network open vol. 4,6 (2021): e2114923. doi: https://doi.org/10.1001/jamanetworkopen.2021.14923
Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J, Taron J, Zhai BK, Burdo T, Fitch KV, Kileel EM, Williams K, Fichtenbaum CJ, Overton ET, Malvestutto C, Aberg J, Currier J, Sponseller CA, Melbourne K, Floris-Moore M, Van Dam C, Keefer MC, Koletar SL, Douglas PS, Ribaudo H, Mayrhofer T, Grinspoon SK. Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention. JAMA Netw Open. 2021 Jun 01;4(6):e2114923. doi: 10.1001/jamanetworkopen.2021.14923. PMID: 34185068; PMCID: PMC8243232.
Copy Download .nbib Format: NLM
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

medRxiv : the preprint server for health sciences

Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF.
PMID: 34981068
medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485.

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain.METHODS: This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer...

Cite
Sullivan DJ, Gebo KA, Shoham S, et al. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021;doi: 10.1101/2021.12.10.21267485.
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R., & Hanley, D. F. (2021). Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.10.21267485
Sullivan, David J, et al. "Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.10.21267485
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485. PMID: 34981068; PMCID: PMC8722611.
Copy Download .nbib Format: NLM
Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C.
PMID: 34861267
Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30.

BACKGROUND AND PURPOSE: Advances in high-dose-rate brachytherapy to treat prostate cancer hinge on improved accuracy in navigation and targeting while optimizing a streamlined workflow. Multimodal image registration and electromagnetic (EM) tracking are two technologies integrated into a prototype system...

Cite
Grajales D, Kadoury S, Shams R, et al. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021;166:154-161doi: 10.1016/j.radonc.2021.11.026.
Grajales, D., Kadoury, S., Shams, R., Barkati, M., Delouya, G., Béliveau-Nadeau, D., Nicolas, B., Le, W. T., Benhacene-Boudam, M. K., Juneau, D., DaSilva, J. N., Carrier, J. F., Hautvast, G., & Ménard, C. (2021). Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 166154-161. https://doi.org/10.1016/j.radonc.2021.11.026
Grajales, David, et al. "Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. 166 (2021): 154-161. doi: https://doi.org/10.1016/j.radonc.2021.11.026
Grajales D, Kadoury S, Shams R, Barkati M, Delouya G, Béliveau-Nadeau D, Nicolas B, Le WT, Benhacene-Boudam MK, Juneau D, DaSilva JN, Carrier JF, Hautvast G, Ménard C. Performance of an integrated multimodality image guidance and dose-planning system supporting tumor-targeted HDR brachytherapy for prostate cancer. Radiother Oncol. 2021 Nov 30;166:154-161. doi: 10.1016/j.radonc.2021.11.026. Epub 2021 Nov 30. PMID: 34861267.
Copy Download .nbib Format: NLM
Understanding religious attachment among christians seeking spiritually integrated psychotherapies: A mixed methods study.

Journal of clinical psychology

Currier JM, Stevens LT, Hinkel HM, Davis EB, Park CL.
PMID: 34600444
J Clin Psychol. 2021 Oct 02; doi: 10.1002/jclp.23258. Epub 2021 Oct 02.

OBJECTIVE: This mixed methods study aimed to understand ways of viewing and experiencing religious attachment among Christians in spiritually integrated psychotherapies.METHOD: In total, 190 Christian-affiliated clients completed narrative responses about religious and parental attachment along with validated measures of...

Cite
Currier JM, Stevens LT, Hinkel HM, et al. Understanding religious attachment among christians seeking spiritually integrated psychotherapies: A mixed methods study. J Clin Psychol. 2021;doi: 10.1002/jclp.23258.
Currier, J. M., Stevens, L. T., Hinkel, H. M., Davis, E. B., & Park, C. L. (2021). Understanding religious attachment among christians seeking spiritually integrated psychotherapies: A mixed methods study. Journal of clinical psychology, . https://doi.org/10.1002/jclp.23258
Currier, Joseph M, et al. "Understanding religious attachment among christians seeking spiritually integrated psychotherapies: A mixed methods study." Journal of clinical psychology vol. (2021). doi: https://doi.org/10.1002/jclp.23258
Currier JM, Stevens LT, Hinkel HM, Davis EB, Park CL. Understanding religious attachment among christians seeking spiritually integrated psychotherapies: A mixed methods study. J Clin Psychol. 2021 Oct 02; doi: 10.1002/jclp.23258. Epub 2021 Oct 02. PMID: 34600444.
Copy Download .nbib Format: NLM
Change in pelvic incidence between the supine and standing positions in patients with bilateral sacroiliac joint vacuum signs.

Journal of neurosurgery. Spine

Mikula AL, Fogelson JL, Oushy S, Pinter ZW, Peters PA, Abode-Iyamah K, Sebastian AS, Freedman B, Currier BL, Polly DW, Elder BD.
PMID: 33450735
J Neurosurg Spine. 2021 Jan 15;34(4):617-622. doi: 10.3171/2020.8.SPINE20742.

OBJECTIVE: Pelvic incidence (PI) is a commonly utilized spinopelvic parameter in the evaluation and treatment of patients with spinal deformity and is believed to be a fixed parameter. However, a fixed PI assumes that there is no motion across...

Cite
Mikula AL, Fogelson JL, Oushy S, et al. Change in pelvic incidence between the supine and standing positions in patients with bilateral sacroiliac joint vacuum signs. J Neurosurg Spine. 2021;34(4):617-622doi: 10.3171/2020.8.SPINE20742.
Mikula, A. L., Fogelson, J. L., Oushy, S., Pinter, Z. W., Peters, P. A., Abode-Iyamah, K., Sebastian, A. S., Freedman, B., Currier, B. L., Polly, D. W., & Elder, B. D. (2021). Change in pelvic incidence between the supine and standing positions in patients with bilateral sacroiliac joint vacuum signs. Journal of neurosurgery. Spine, 34(4), 617-622. https://doi.org/10.3171/2020.8.SPINE20742
Mikula, Anthony L, et al. "Change in pelvic incidence between the supine and standing positions in patients with bilateral sacroiliac joint vacuum signs." Journal of neurosurgery. Spine vol. 34,4 (2021): 617-622. doi: https://doi.org/10.3171/2020.8.SPINE20742
Mikula AL, Fogelson JL, Oushy S, Pinter ZW, Peters PA, Abode-Iyamah K, Sebastian AS, Freedman B, Currier BL, Polly DW, Elder BD. Change in pelvic incidence between the supine and standing positions in patients with bilateral sacroiliac joint vacuum signs. J Neurosurg Spine. 2021 Jan 15;34(4):617-622. doi: 10.3171/2020.8.SPINE20742. PMID: 33450735.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 203 entries